Chesley Taft & Associates’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-13,198
| Closed | -$1.14M | – | 381 |
|
|
2026
Q1 | $1.14M | Sell |
13,198
-64
| -0.5% | -$6.13K | 0.05% | 205 |
|
|
2025
Q4 | $1.27M | Buy |
13,262
+2,025
| +18% | +$197K | 0.05% | 194 |
|
|
2025
Q3 | $1.07M | Buy |
+11,237
| New | +$1.03M | 0.05% | 199 |
|
|
2021
Q4 | – | Sell |
-2,941
| Closed | -$369K | – | 302 |
|
|
2021
Q3 | $369K | Buy |
2,941
+23
| +0.8% | +$2.98K | 0.02% | 255 |
|
|
2021
Q2 | $362K | Buy |
2,918
+400
| +16% | +$50.2K | 0.02% | 255 |
|
|
2021
Q1 | $303K | Buy |
2,518
+78
| +3% | +$9.14K | 0.02% | 264 |
|
|
2020
Q4 | $286K | Buy |
2,440
+3
| +0.1% | +$330 | 0.02% | 258 |
|
|
2020
Q3 | $253K | Hold |
2,437
| – | – | 0.02% | 246 |
|
|
2020
Q2 | $223K | Buy |
+2,437
| New | +$234K | 0.02% | 247 |
|
|
2020
Q1 | – | Sell |
-1,829
| Closed | -$208K | – | 261 |
|
|
2019
Q4 | $208K | Buy |
+1,829
| New | +$201K | 0.02% | 261 |
|
|
2019
Q2 | – | Sell |
-10,029
| Closed | -$913K | – | 255 |
|
|
2019
Q1 | $913K | Buy |
10,029
+1,050
| +12% | +$94K | 0.08% | 161 |
|
|
2018
Q4 | $817K | Buy |
+8,979
| New | +$839K | 0.08% | 160 |
|
|
2016
Q4 | – | Sell |
-6,176
| Closed | -$534K | – | 270 |
|
|
2016
Q3 | $534K | Sell |
6,176
-300
| -5% | -$26.1K | 0.05% | 198 |
|
|
2016
Q2 | $562K | Sell |
6,476
-1
| -0% | -$81 | 0.06% | 195 |
|
|
2016
Q1 | $486K | Sell |
6,477
-5
| -0.1% | -$377 | 0.05% | 196 |
|
|
2015
Q4 | $499K | Buy |
6,482
+306
| +5% | +$23K | 0.05% | 197 |
|
|
2015
Q3 | $413K | Sell |
6,176
-200
| -3% | -$14.7K | 0.05% | 186 |
|
|
2015
Q2 | $472K | Hold |
6,376
| – | – | 0.05% | 184 |
|
|
2015
Q1 | $497K | Sell |
6,376
-933
| -13% | -$70.7K | 0.05% | 185 |
|
|
2014
Q4 | $528K | Sell |
7,309
-350
| -5% | -$24.3K | 0.05% | 184 |
|
|
2014
Q3 | $474K | Hold |
7,659
| – | – | 0.05% | 182 |
|
|
2014
Q2 | $488K | Sell |
7,659
-1,500
| -16% | -$91.1K | 0.05% | 187 |
|
|
2014
Q1 | $564K | Buy |
9,159
+1,400
| +18% | +$81.5K | 0.06% | 180 |
|
|
2013
Q4 | $445K | Sell |
7,759
-750
| -9% | -$42.5K | 0.04% | 216 |
|
|
2013
Q3 | $453K | Hold |
8,509
| – | – | 0.05% | 212 |
|
|
2013
Q2 | $438K | Buy |
+8,509
| New | +$421K | 0.05% | 212 |
|
Other funds holding MDT
Chesley Taft & Associates's MDT Position: Q2 2026 in Review
Chesley Taft & Associates sold out of Medtronic (MDT) in Q2 2026, closing a stake of 13,198 shares — an estimated $1.14M sold.
Chesley Taft & Associates first reported a position in MDT in Q2 2013 and held it in 26 quarters. The position peaked at $1.27M in Q4 2025. 2,135 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Chesley Taft & Associates reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
- Chesley Taft & Associates sold 13,198 Medtronic shares in Q2 2026, an estimated $1.14M.
- Chesley Taft & Associates first reported a position in Medtronic in Q2 2013 and held it in 26 quarters.
- Chesley Taft & Associates's Medtronic position peaked at $1.27M in Q4 2025.
- 2,135 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.